Previous 10 | Next 10 |
CASI PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT PR Newswire ROCKVILLE, Md. and BEIJING , May 26, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative t...
Casi Pharmaceuticals (NASDAQ:CASI) is granting Beijing Tianshi Tongda Pharmaceuticals Technology an exclusive, perpetual, worldwide license for CID-103 for autoimmune diseases. Under the sublicense agreement, Casi will maintain the exclusive commercialization and co-marketing rights...
CASI PHARMACEUTICALS ENTERES INTO SUBLICENSE AGREEMENT WITH TIANSHI PHARMACEUTICALS FOR ANTI-CD38 MONOCLONAL ANTIBODY (MAB) CID-103 IN AUTOIMMUNE FIELD PR Newswire ~ CASI to receive upfront payment of $10 million in two instalments ~ ~ CASI through its whol...
The following slide deck was published by CASI Pharmaceuticals, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: CASI Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation
CASI Pharmaceuticals, Inc. (CASI) Q1 2022 Earnings Conference Call May 12, 2022, 08:00 AM ET Company Participants Wei-Wu He - Chairman and Chief Executive Officer Wei Zhang - President Larry Zhang - President Alexander Zukiwski - Executive Vice President and Chief Medical Officer James Goldsc...
CASI Pharmaceuticals press release (NASDAQ:CASI): Q1 GAAP EPS of -$0.06 beats by $0.03. Revenue of $9.06M (+57.8% Y/Y) misses by $0.18M. For further details see: CASI Pharmaceuticals GAAP EPS of -$0.06 beats by $0.03, revenue of $9.06M misses by $0.18M
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS PR Newswire ROCKVILLE, Md. and BEIJING , May 12, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commer...
CASI Pharmaceuticals (NASDAQ:CASI) Q1 consensus EPS estimate is -$0.06 and consensus revenue estimate is $9.24M (+61.0% Y/Y). CASI is scheduled to announce Q1 earnings results on Thursday, May 12, before market open. For further details see: CASI Pharmaceuticals Q1 2022 E...
AADI,ACHR,ACTG,ADN,AEG,OTCPK:ALIZF,ALT,AMTX,OTCPK:ARNGF,ARQQ,ATY,BAM,BGRY,BKKT,BT,CAMT,CASI,CORR,CPG,CYBR,CYXT,DAVA,DCBO,DRIO,EMAN,EURN,GENI,HIMX,OTCPK:HNHAF,HUT,IS,KNOP,KT,LQDA,MGIC,OTCPK:MKGAF,ML,MOGO,MTNB,NETI,NICE,OTCPK:NSANY,NVMI,ORTX,PCT,OTCPK:PEYUF,OTCQX:QTRHF,RDCM,OTCPK:RWEOY,SCYX,SFL...
CASI PHARMACEUTICALS TO REPORT FIRST QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL MAY 12, 2022 PR Newswire ROCKVILLE, Md. and BEIJING , May 2, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused ...
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
2024-07-17 13:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP PR Newswire BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing in...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...